Free Trial

Vertex Pharmaceuticals (VRTX) SEC Filings & 10K Form

Vertex Pharmaceuticals logo
$458.27 +7.30 (+1.62%)
(As of 05:15 PM ET)

Recent Vertex Pharmaceuticals SEC Filings

DateFilerForm TypeView
11/15/2024
9:31 AM
ALTSHULER DAVID (Reporting)
Vertex Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/13/2024
3:15 PM
Vertex Pharmaceuticals (Issuer)
WAGNER CHARLES F JR (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/08/2024
1:58 PM
Kewalramani Reshma (Reporting)
Vertex Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/05/2024
3:11 PM
Vertex Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/17/2024
3:12 PM
SACHS BRUCE I (Reporting)
Vertex Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/03/2024
3:12 PM
Biller Jonathan (Reporting)
Vertex Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/02/2024
9:04 AM
Biller Jonathan (Reporting)
Vertex Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/30/2024
3:47 PM
Bhatia Sangeeta N. (Reporting)
Vertex Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/30/2024
3:23 PM
LEIDEN JEFFREY M (Reporting)
Vertex Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/12/2024
3:08 PM
Bhatia Sangeeta N. (Reporting)
Vertex Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/08/2024
10:47 AM
Bhatia Sangeeta N. (Reporting)
Vertex Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/07/2024
8:52 AM
Bozic Carmen (Reporting)
Vertex Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/01/2024
3:17 PM
Kewalramani Reshma (Reporting)
Vertex Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/01/2024
2:34 PM
SACHS BRUCE I (Reporting)
Vertex Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/30/2024
2:25 PM
Kewalramani Reshma (Reporting)
Vertex Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/25/2024
3:06 PM
Bozic Carmen (Reporting)
Vertex Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/24/2024
3:05 PM
Kewalramani Reshma (Reporting)
Vertex Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/24/2024
11:27 AM
Bozic Carmen (Reporting)
Vertex Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/22/2024
12:16 PM
Kewalramani Reshma (Reporting)
Vertex Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/10/2024
9:27 AM
Bozic Carmen (Reporting)
Vertex Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/26/2024
9:23 AM
Bozic Carmen (Reporting)
Vertex Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/13/2024
3:09 PM
Atkinson Edward Morrow III (Reporting)
Vertex Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/13/2024
3:11 PM
Bozic Carmen (Reporting)
Vertex Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/12/2024
8:54 AM
Bozic Carmen (Reporting)
Vertex Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/12/2024
8:56 AM
Atkinson Edward Morrow III (Reporting)
Vertex Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/05/2024
3:11 PM
Vertex Pharmaceuticals (Issuer)
WAGNER CHARLES F JR (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/03/2024
3:09 PM
Tatsis Ourania (Reporting)
Vertex Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/03/2024
12:56 PM
Vertex Pharmaceuticals (Subject)
WAGNER CHARLES F JR (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/03/2024
12:38 PM
Tatsis Ourania (Reporting)
Vertex Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/31/2024
9:50 AM
Tatsis Ourania (Reporting)
Vertex Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/30/2024
10:48 AM
Tatsis Ourania (Reporting)
Vertex Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/29/2024
3:08 PM
Kewalramani Reshma (Reporting)
Vertex Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/29/2024
9:05 AM
Bozic Carmen (Reporting)
Vertex Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/28/2024
9:51 AM
Vertex Pharmaceuticals (Subject)
WAGNER CHARLES F JR (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/24/2024
12:13 PM
Kewalramani Reshma (Reporting)
Vertex Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/22/2024
3:21 PM
Kewalramani Reshma (Reporting)
Vertex Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/22/2024
12:45 PM
SACHS BRUCE I (Reporting)
Vertex Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/20/2024
2:32 PM
Kewalramani Reshma (Reporting)
Vertex Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/20/2024
7:36 AM
Vertex Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/20/2024
7:25 AM
ALPINE IMMUNE SCIENCES, INC. (Subject)
Vertex Pharmaceuticals (Filed by)
Form SC TO-T/A
05/15/2024
11:20 AM
Sachdev Amit (Reporting)
Vertex Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
I've got news for you… (Ad)

Today, I’m doing something I thought I’d never do… Especially since I’m not normally a “swing for the fences” type of trader. But I’ve been quietly testing a new type of trade for a while now… And the returns are too good not to share with you. Take a look… I can’t guarantee results or against losses, but if you want to discover how I’ll target the triple return before the end of the week

watch this FREE briefing with me and expert trader Graham Lindman
05/15/2024
10:41 AM
ALTSHULER DAVID (Reporting)
Vertex Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/15/2024
10:50 AM
Arbuckle Stuart A (Reporting)
Vertex Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/10/2024
7:01 AM
ALPINE IMMUNE SCIENCES, INC. (Subject)
Vertex Pharmaceuticals (Filed by)
Form SC TO-T/A
05/08/2024
7:54 AM
ALPINE IMMUNE SCIENCES, INC. (Subject)
Vertex Pharmaceuticals (Filed by)
Form SC TO-T/A
05/03/2024
3:05 PM
Bhatia Sangeeta N. (Reporting)
Vertex Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/02/2024
9:07 AM
Bhatia Sangeeta N. (Reporting)
Vertex Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/22/2024
3:15 PM
ALPINE IMMUNE SCIENCES, INC. (Subject)
Vertex Pharmaceuticals (Filed by)
Form SC TO-T
04/16/2024
3:56 PM
Arjuna Capital (Filed by)
Vertex Pharmaceuticals (Subject)
Form PX14A6G
04/11/2024
3:08 PM
ALPINE IMMUNE SCIENCES, INC. (Subject)
Vertex Pharmaceuticals (Filed by)
Form SC TO-C
04/11/2024
6:13 AM
Vertex Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/11/2024
6:17 AM
Vertex Pharmaceuticals (Subject)
Form SC TO-C
04/10/2024
4:22 PM
ALPINE IMMUNE SCIENCES, INC. (Subject)
Vertex Pharmaceuticals (Filed by)
Form SC TO-C
04/10/2024
11:14 AM
Capital World Investors (Filed by)
Vertex Pharmaceuticals (Subject)
Form SC 13G/A
04/04/2024
3:05 PM
Vertex Pharmaceuticals (Filer)
Form ARS
02/27/2024
3:44 PM
Atkinson Edward Morrow III (Reporting)
Vertex Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/27/2024
3:37 PM
Arbuckle Stuart A (Reporting)
Vertex Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/27/2024
3:24 PM
ALTSHULER DAVID (Reporting)
Vertex Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/26/2024
12:19 PM
Arbuckle Stuart A (Reporting)
Vertex Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/26/2024
10:25 AM
ALTSHULER DAVID (Reporting)
Vertex Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/26/2024
10:10 AM
Tatsis Ourania (Reporting)
Vertex Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/26/2024
9:44 AM
Atkinson Edward Morrow III (Reporting)
Vertex Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/26/2024
9:52 AM
Sachdev Amit (Reporting)
Vertex Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/26/2024
9:26 AM
Sanna Bastiano (Reporting)
Vertex Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/23/2024
3:28 PM
Tatsis Ourania (Reporting)
Vertex Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/23/2024
3:16 PM
Atkinson Edward Morrow III (Reporting)
Vertex Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/21/2024
3:43 PM
Tatsis Ourania (Reporting)
Vertex Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/21/2024
3:49 PM
Vertex Pharmaceuticals (Issuer)
WAGNER CHARLES F JR (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/21/2024
3:38 PM
Sachdev Amit (Reporting)
Vertex Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/21/2024
3:26 PM
Bozic Carmen (Reporting)
Vertex Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/21/2024
3:29 PM
Kewalramani Reshma (Reporting)
Vertex Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/21/2024
10:38 AM
Arbuckle Stuart A (Reporting)
Vertex Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/21/2024
9:44 AM
Tatsis Ourania (Reporting)
Vertex Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/21/2024
9:52 AM
Atkinson Edward Morrow III (Reporting)
Vertex Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/21/2024
9:16 AM
ALTSHULER DAVID (Reporting)
Vertex Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/21/2024
8:50 AM
Sanna Bastiano (Reporting)
Vertex Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/21/2024
8:43 AM
Sachdev Amit (Reporting)
Vertex Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/20/2024
10:03 AM
Tatsis Ourania (Reporting)
Vertex Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/20/2024
10:29 AM
Arbuckle Stuart A (Reporting)
Vertex Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/20/2024
9:57 AM
ALTSHULER DAVID (Reporting)
Vertex Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/20/2024
9:32 AM
Sanna Bastiano (Reporting)
Vertex Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/20/2024
9:22 AM
Sachdev Amit (Reporting)
Vertex Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/20/2024
9:22 AM
Atkinson Edward Morrow III (Reporting)
Vertex Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/15/2024
10:19 AM
LEIDEN JEFFREY M (Reporting)
Vertex Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/14/2024
4:11 PM
Sanna Bastiano (Reporting)
Vertex Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/13/2024
4:34 PM
Vertex Pharmaceuticals (Issuer)
WAGNER CHARLES F JR (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/13/2024
4:23 PM
Tatsis Ourania (Reporting)
Vertex Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/12/2024
12:42 PM
Biller Jonathan (Reporting)
Vertex Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/12/2024
12:24 PM
Atkinson Edward Morrow III (Reporting)
Vertex Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/12/2024
11:44 AM
Arbuckle Stuart A (Reporting)
Vertex Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/12/2024
10:32 AM
Tatsis Ourania (Reporting)
Vertex Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
This Bull Market Indicator called NVDA at $116 (Ad)

Every now and again we find an investment idea so incredible we can’t help but share. And today is one of those rare days… Except, today we won't be giving you insight on any one particular stock… But rather, insight on a revolutionary new stock picking indicator… In fact, within the last year, this indicator has become famous for a multitude of reasons… But one of the biggest was because of the buy signal it issued on October 18th, 2022. In fact, on that very day, it said to buy NVDA at $116.37… Anyone who did would be sitting on a tremendously large return today… But even if you missed the original buy signal from October, this incredible indicator issued 11 other buy signals while Nvidia made its epic run…

All you have to do is follow this link here
02/12/2024
9:32 AM
ALTSHULER DAVID (Reporting)
Vertex Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/12/2024
8:52 AM
Sachdev Amit (Reporting)
Vertex Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/09/2024
5:19 PM
Capital World Investors (Filed by)
Vertex Pharmaceuticals (Subject)
Form SC 13G/A
02/09/2024
9:05 AM
FMR LLC (Filed by)
Vertex Pharmaceuticals (Subject)
Form SC 13G/A
02/08/2024
3:38 PM
Kewalramani Reshma (Reporting)
Vertex Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/08/2024
3:40 PM
LEIDEN JEFFREY M (Reporting)
Vertex Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/08/2024
3:43 PM
Sachdev Amit (Reporting)
Vertex Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/08/2024
3:45 PM
Tatsis Ourania (Reporting)
Vertex Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/08/2024
3:47 PM
Vertex Pharmaceuticals (Issuer)
WAGNER CHARLES F JR (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:VRTX) was last updated on 11/25/2024 by MarketBeat.com Staff
From Our Partners